Jose Antonio Amat, MD

Paul S. Appelbaum, M.D., the Elizabeth K. Dollard Professor of Psychiatry, Medicine and Law, and Director, Division of Law, Ethics and Psychiatry at Columbia, was previously A.F. Zeleznik Distinguished Professor and Chairman, Department of Psychiatry; and Director, Law and Psychiatry Program, University of Massachusetts Medical School. Dr. Appelbaum is the author of many articles and books on law and ethics in clinical practice. Dr. Appelbaum is Past President of the American Psychiatric Association, the American Academy of Psychiatry and the Law, and the Massachusetts Psychiatric Society, and has twice served as Chair of the Council on Psychiatry and Law and of the Committee on Judicial Action for the American Psychiatric Association (APA). Dr. Appelbaum is currently Chair of the DSM Steering Committee for APA, and of the Standing Committee on Ethics of the World Psychiatric Association. He has received the Isaac Ray Award of the American Psychiatric Association for "outstanding contributions to forensic psychiatry and the psychiatric aspects of jurisprudence," was the Fritz Redlich Fellow at the Center for Advanced Study in the Behavioral Sciences, and has been elected to the Institute of Medicine of the National Academy of Sciences. Dr. Appelbaum performs forensic evaluations in civil and criminal cases, and treats patients with a broad variety of problems, including depression, anxiety, and adjustment problems.

Frances Rudnick Levin, MD is the Kennedy-Leavy Professor of Psychiatry at Columbia University and the Chief of the Division on Substance Use Disorders at NYSPI/Columbia University. For over twenty years, she served as the Director of the Addiction Psychiatry Fellowship Program at New York-Presbyterian Hospital and for the past sixteen years, she has been the PI of a T32 NIDA funded Substance Abuse Research Fellowship which has been continuously funded since 1994. Dr. Levin graduated from Cornell University Medical College and completed her psychiatric residency at the New York Hospital-Payne Whitney Clinic. Subsequently, she graduated from a 2-year combined clinical and research fellowship at the University of Maryland and the Addiction Research Center, the intramural branch of the National Institute on Drug Abuse (NIDA). Currently, she serves as the Medical Director of the Providers’ Clinical Support System (PCSS), a SAMHSA-supported national training and mentoring initiative focused on addressing the opioid use disorder crisis. Also, she is the Medical Director of a SAMHSA-supported State Targeted Response technical assistance grant (the Opioid Response Network) to address the national opioid epidemic. Dr. Levin, working with other senior faculty, inaugurated the university-wide Center for Healing of Opioid and Other Substance Use Disorders: Enhancing Intervention Development and Implementation (CHOSEN) in 2020 and serves as one of the senior Directors. Moreover, she is the principal investigator of several federal grants, including a K24 Mid-Career Investigator Award as well as a Co-Investigator on numerous other grants. Her current research interests include pharmacologic and psychotherapeutic treatment interventions for opioid, cocaine and marijuana use disorders, and treatment approaches for adults with substance use disorders and attention-deficit hyperactivity disorder along with other psychiatric illnesses. Dr. Levin has over two-hundred and fifty articles and book chapters on a wide range of topics including treatments of substance use disorders, assessment, and treatment of co-occurring psychiatric illnesses and vulnerabilities associated with substance use disorders. She has served on several advisory panels and ad-hoc federal grant review groups and was a member of the NIDA – Initial Review Group: Training and Career Development Subcommittee for eight years and served as a member to the NIDA Interventions to Prevent and Treat Addiction (IPTA). She is currently on the Board of Directors for the American Academy of Addiction Psychiatry (AAAP), the College on Drug Dependence (CPDD), and the American Society of ADHD and Related Disorders (APSARD). She is an editorial board member of three journals, past President of the American Academy of Addiction Psychiatry, and past Chair of the APA Council on Addiction Psychiatry.

Melissa Arbuckle, MD, PhD is Vice Chair for Education and Director of Resident Education in the Department of Psychiatry at Columbia and the New York State Psychiatric Institute. Dr. Arbuckle is a national leader in residency training in psychiatry and is a past-president of the American Association of Directors of Psychiatric Residency Training (AADPRT). Dr. Arbuckle's academic interests focus on the role of medical education in advancing the translation of research into the practice of psychiatry. Dr. Arbuckle is a principal investigator on Columbia’s NIH funded R25 Research Track. This program, “Priming the Pump: Training Physician-Scientists in Translational Psychiatry,” aims to support the development of physician-scientists who are dedicated to translational research in psychiatry. As part of her effort to expand the translation of basic neuroscience to clinical practice, Dr. Arbuckle is also Senior Director of the National Neuroscience Curriculum Initiative (NNCI), an NIH funded collaboration to create, pilot, and disseminate a comprehensive set of shared resources to help train psychiatrists to integrate a modern neuroscience perspective into their clinical work. In bridging patient-oriented and population-based research, Dr. Arbuckle has been extensively involved in developing quality improvement (QI) training programs for residents in psychiatry. Her training program in QI has been recognized as a “model curriculum” by the AADPRT. Dr. Arbuckle is also a member of the steering committee for Columbia’s NIH funded T32 Research Fellowship in Global Mental Health, which is focused on training fellows in implementation and dissemination research in order to identify and develop models for effective mental health care delivery in low- and middle-income countries.